YUROXAN
DEAD

Serial Number

78264418

Owner

MEDIGENE AG

Attorney

Adrienne L. White, Esq.

Filing Date

Jun 19, 2003

Add to watchlist:

No watchlists yet
View on USPTO

YUROXAN Trademark

Serial Number: 78264418 • Registration: 2917240

YUROXAN is a trademark filed by MEDIGENE AG on June 19, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

MEDIGENE AG (25 trademarks)

Lochhamer Strasse 11
MARTINSRIED, MUNICH , DE

Entity Type: 03

Trademark Details

Filing Date

June 19, 2003

Registration Date

January 11, 2005

Published for Opposition

October 19, 2004

Cancellation Date

September 3, 2014

Goods & Services

PHARMACEUTICAL AND VETERINARY MEDICAL PRODUCTS FOR MEDICAL PURPOSES, NAMELY, PHARMACEUTICAL PREPARATIONS FOR USE IN TREATING THE SKIN DISEASES OF WARTS, GENITAL WARTS, ACTINIC KERATOSIS, PSORIASIS, DERMATITIS, HERPES, ALOPECIA, ATOPIC DERMATITIS, CUTANEOUS ATOPY, CUTANEOUS T-CELL LYMPHOMA, DARRIER'S DISEASE, DARTROUD DISTHESIS, DERMATITIS, ECZEMA, GENITAL HERPES, HERPES, HYPERKERATOSIS, HYPERPIGMENTATION, HYPERPLASIA OF THE EPIDERMIS, HYPOPIGMENTATION, ICHTHYOSIS, INCREASED PROLIFERATION OF SKIN CELLS, KELOIDS, LENTIGO, LICHEN PLANUS, MELASMA, MOLLUSCUM, CONTAGIOSUM, MYCOSIS FUNGOIDES, NEOPLASIAS, NEURODERMITIS, PIGMENTATION DISORDERS, POROKERATOSIS OF MIBELLI, PSORIASIS, REMOVAL OF TATOOS, ROSACEA, SEBORRHEA, SHINGLES, SKIN DISEASES RELATED TO INFLAMMATORY PROCESSES OF SKIN CELLS, SKIN ULCERS, VITILIGO, WARTS, XEROSIS, AND MEDICATED SKIN PREPARATIONS FOR USE IN TREATING THE TUMOROUS DISEASES OF GLIOMA, CARCINOMA OF THE COLON, OVARIAN CARCINOMA, CERVICAL CARCINOMA, CARCINOMA OF THE PROSTATE, MELANOMA, ASTROCYTOMAS, BASEL CELL CARCINOMAS, BILIARY CANCERS, BLADDER CANCERS, BONE CANCERS, BRAIN CANCERS, BREAST CANCERS, CARCINOMAS, CERVICAL CANCERS, CERVICAL INTRAEPITHELIAL NEOPLASIAS, COLORECTAL CANCERS, ENDROCRINE SYSTEM CANCERS, EPENDYMOMAS, IPIDERMOID CARCINOMAS, FIBROSARCOMAS, GASTRIC CANCERS, GASTROINTESTINAL CANCERS, GLIOBLASTOMAS, GYNECOLOGIC CANCERS, HEAD AND NECK CANCERS, HEMANGIOMAS, HEPATOMAS, HODGKIN'S LYMPHOMAS, LEUKEMIA, LIVER CANCERS, LUNG CANCERS, LYMPHOMAS, MEDULLOBLASTOMAS, MENINGIOMAS, MESOTHELAIOMAS, METASTASES, MYBLOMAS, NEOPLASIAS, NEURECTODERMAL CANCERS, NEUROBLASTOMAS, NEUROFIBROMAS, NEUROFIBROSARCOMAS, NEURONAL CANCERS, NON-HODGKIN'S LYMPHOMAS, OLIGODENDROGLIOMAS, PANCREATIC CANCERS, PEDIATRIC CANCERS, PENILE CANCER, PITUTIARY ADENOMAS, PLEURAL CANCERS, RENAL CELL CARCINOMAS, SARCOMAS, SCHWANNOMAS, SKIN CANCERS, SQAMOUS CELL CARCINOMAS, TESTICULAR CANCERS, THYROID CANCERS, THYROID TUMOURS, UNINARY TRACT CANCERS

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 3, 2014 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 24, 2009 TCCA
REGISTERED-PRINCIPAL REGISTER
Jan 11, 2005 R.PR
PUBLISHED FOR OPPOSITION
Oct 19, 2004 PUBO
NOTICE OF PUBLICATION
Sep 29, 2004 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 19, 2004 PREV
ASSIGNED TO LIE
Aug 19, 2004 ALIE
ASSIGNED TO LIE
Aug 17, 2004 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2004 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 6, 2004 TCCA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2004 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2004 CRFA
PAPER RECEIVED
May 21, 2004 MAIL
NON-FINAL ACTION E-MAILED
Dec 2, 2003 GNRT
ASSIGNED TO EXAMINER
Nov 11, 2003 DOCK